2023 Clinical Trials Conditions Data 
Project CBD
MARCH 21, 2023
She was upset with herself for being so careless and concerned that the condition would persist. For many other people of all ages, tinnitus is indeed a chronic condition that has nothing to do with loud ‘80s cover bands in small clubs. And it’s not just ringing. A review of the current literature.” And its conclusion?
Cannabis Law Report
AUGUST 18, 2022
“We are at the beginning of a revolution in how mental health conditions are medically treated. Psychedelics present a new potential path to relief for patients who continue to struggle with mental health conditions despite conventional therapies,” he added. Tweet this. ” Joining Ms.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
DECEMBER 21, 2021
Also in November, it reported positive data on its standout IND, CYB003. Within a few months, it had completed the first phase of its clinical trial of DMT in combination with supportive psychotherapy and commenced a phase 2a trial. Small Pharma (CVE: DMT ) (OTCMKTS: DMTTF ).
Cannabis Law Report
MAY 29, 2022
As previously mentioned, clinical studies are promising, including a Phase 3 trial (the last step before submitting an NDA) completed last November. [9] 9] Experts predict that this therapy could receive full FDA approval as soon as 2023. [10] Clinical Trials and Human Subject Protections. Challenges.
Cannabis Law Report
FEBRUARY 9, 2022
But this is the first time Oregonians have been allowed to see some of the nuts and bolts of what some predict could grow into a billion-dollar industry nationally, according to Data Bridge Market Research. Scientists don’t know why this condition occurs, but it isn’t believed to happen with Psilocybe cubensis. Source: [link].
Project CBD
FEBRUARY 27, 2023
Researchers have been investigating the use of cannabis to treat fibromyalgia’s constellation of symptoms for decades, with early clinical trials in the 2000s 1-4 suggesting a possible benefit of both pure THC and flower in managing the disease. It’s not a new idea.
Project CBD
MAY 3, 2023
Dr. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. CannMed: For what conditions do you think CBG has the most promise? It can be a very difficult condition. What are you most interested in?
Expert insights. Personalized for you.
144 
Let's personalize your content